EP3946392A4 - Probiotic biofilm compositions and methods of preparing same - Google Patents
Probiotic biofilm compositions and methods of preparing same Download PDFInfo
- Publication number
- EP3946392A4 EP3946392A4 EP20776481.2A EP20776481A EP3946392A4 EP 3946392 A4 EP3946392 A4 EP 3946392A4 EP 20776481 A EP20776481 A EP 20776481A EP 3946392 A4 EP3946392 A4 EP 3946392A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- preparing same
- biofilm compositions
- probiotic biofilm
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/368,030 US10709744B1 (en) | 2019-03-28 | 2019-03-28 | Probiotic biofilm suppositories |
US201962827931P | 2019-04-02 | 2019-04-02 | |
PCT/IL2020/050380 WO2020194319A1 (en) | 2019-03-28 | 2020-03-29 | Probiotic biofilm compositions and methods of preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3946392A1 EP3946392A1 (en) | 2022-02-09 |
EP3946392A4 true EP3946392A4 (en) | 2022-12-07 |
Family
ID=72610340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20776481.2A Pending EP3946392A4 (en) | 2019-03-28 | 2020-03-29 | Probiotic biofilm compositions and methods of preparing same |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3946392A4 (en) |
JP (1) | JP2022535323A (en) |
KR (1) | KR20220016042A (en) |
CN (1) | CN113766923A (en) |
AU (1) | AU2020250170A1 (en) |
BR (1) | BR112021019437A2 (en) |
CA (1) | CA3131165A1 (en) |
IL (1) | IL286704A (en) |
MX (1) | MX2021011628A (en) |
SG (1) | SG11202110741YA (en) |
WO (1) | WO2020194319A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023195008A1 (en) * | 2022-04-05 | 2023-10-12 | Mybiotics Pharma Ltd. | Bacterial compositions and methods for growing bacteria on particles |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009092810A2 (en) * | 2008-01-24 | 2009-07-30 | Bacterfield Oü | Single pharmaceutical composition containing antibiotics and probiotics |
US20120247993A1 (en) * | 2008-11-14 | 2012-10-04 | Unistraw Patent Holdings Limited | Probiotic Compositions, Methods and Apparatus for Their Administration |
US20140370107A1 (en) * | 2012-02-01 | 2014-12-18 | Probiotical North America Inc. | Multilayer microincapuslated probiotic bacteria |
WO2017095968A1 (en) * | 2015-11-30 | 2017-06-08 | Imagilin Technology Llc | Compositions comprising probiotics and methods of use thereof |
US20170173091A1 (en) * | 2015-11-10 | 2017-06-22 | Probiotech Llc | Probiotic delivery systems |
WO2017208237A1 (en) * | 2016-05-29 | 2017-12-07 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Method of generating bacterial compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
IT1400821B1 (en) * | 2009-03-09 | 2013-07-02 | Probiotical Spa | OIL SUSPENSION CONTAINING PROBIOTIC BACTERIA FOR PEDIATRIC USE |
JP6754694B2 (en) * | 2014-03-06 | 2020-09-16 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | Probiotic formulations and methods for use |
US10793847B2 (en) * | 2015-05-11 | 2020-10-06 | Mybiotics Pharma Ltd. | Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut |
KR101784847B1 (en) * | 2016-05-10 | 2017-10-13 | 주식회사 하우동천 | A composition comprising lactic acid bacteria for protecting and treating vaginosis disease and the use thereof |
WO2018013583A2 (en) * | 2016-07-11 | 2018-01-18 | The Brigham And Women's Hospital, Inc. | Medicinal vaginal lactobacillus cocktail |
US20190209626A1 (en) * | 2018-01-05 | 2019-07-11 | Human Longevity, Inc. | Probiotic compositions comprising bacteria from bacteroids and firmicutes phyla |
-
2020
- 2020-03-29 EP EP20776481.2A patent/EP3946392A4/en active Pending
- 2020-03-29 JP JP2021558510A patent/JP2022535323A/en active Pending
- 2020-03-29 SG SG11202110741YA patent/SG11202110741YA/en unknown
- 2020-03-29 AU AU2020250170A patent/AU2020250170A1/en not_active Abandoned
- 2020-03-29 CA CA3131165A patent/CA3131165A1/en active Pending
- 2020-03-29 BR BR112021019437A patent/BR112021019437A2/en not_active Application Discontinuation
- 2020-03-29 CN CN202080031956.1A patent/CN113766923A/en active Pending
- 2020-03-29 KR KR1020217034591A patent/KR20220016042A/en unknown
- 2020-03-29 MX MX2021011628A patent/MX2021011628A/en unknown
- 2020-03-29 WO PCT/IL2020/050380 patent/WO2020194319A1/en unknown
-
2021
- 2021-09-26 IL IL286704A patent/IL286704A/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009092810A2 (en) * | 2008-01-24 | 2009-07-30 | Bacterfield Oü | Single pharmaceutical composition containing antibiotics and probiotics |
US20120247993A1 (en) * | 2008-11-14 | 2012-10-04 | Unistraw Patent Holdings Limited | Probiotic Compositions, Methods and Apparatus for Their Administration |
US20140370107A1 (en) * | 2012-02-01 | 2014-12-18 | Probiotical North America Inc. | Multilayer microincapuslated probiotic bacteria |
US20170173091A1 (en) * | 2015-11-10 | 2017-06-22 | Probiotech Llc | Probiotic delivery systems |
WO2017095968A1 (en) * | 2015-11-30 | 2017-06-08 | Imagilin Technology Llc | Compositions comprising probiotics and methods of use thereof |
WO2017208237A1 (en) * | 2016-05-29 | 2017-12-07 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Method of generating bacterial compositions |
Non-Patent Citations (1)
Title |
---|
See also references of WO2020194319A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2022535323A (en) | 2022-08-08 |
WO2020194319A1 (en) | 2020-10-01 |
IL286704A (en) | 2021-10-31 |
SG11202110741YA (en) | 2021-10-28 |
MX2021011628A (en) | 2021-12-10 |
CA3131165A1 (en) | 2020-10-01 |
BR112021019437A2 (en) | 2021-11-30 |
KR20220016042A (en) | 2022-02-08 |
CN113766923A (en) | 2021-12-07 |
EP3946392A1 (en) | 2022-02-09 |
AU2020250170A1 (en) | 2021-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4022059A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3959318A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3965780A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP4037695A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3775203A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3790596A4 (en) | Oligonucleotide compositions and methods of use thereof | |
EP3990562A4 (en) | Adhesive compositions and methods of making the same | |
EP3997115A4 (en) | Il-2 compositions and methods of use thereof | |
EP3976638A4 (en) | Il-2 compositions and methods of use thereof | |
EP3893917A4 (en) | Il-15 compositions and methods of use thereof | |
EP3761972A4 (en) | Bioreactive compositions and methods of use thereof | |
EP4081231A4 (en) | Compositions comprising microbes and methods of use and making thereof | |
EP3856214A4 (en) | Microbial compositions and methods of use | |
EP3829307A4 (en) | Bismuth-thiol compositions and methods of use | |
EP3976070A4 (en) | Shaped organoid compositions and methods of making same | |
EP3731833A4 (en) | Compositions containing thymohydroquinone and their method of preparation | |
EP4034605A4 (en) | Polishing compositions and methods of use thereof | |
EP3606493A4 (en) | Dental cement compositions and methods of use | |
EP4003443A4 (en) | Hydratable and flowable implantable compositions and methods of making and using them | |
EP4045226A4 (en) | Polishing compositions and methods of use thereof | |
EP4142740A4 (en) | Compositions and methods of use thereof | |
EP3840769A4 (en) | Cyclosporine compositions and methods of use | |
EP3843555A4 (en) | Anthocyanin-based colorant compositions and methods of use thereof | |
EP3836938A4 (en) | Solid forms of substituted benzoxaborole and compositions thereof | |
EP4081047A4 (en) | Enzyme compositions and methods of making them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211028 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20221104 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12R 1/225 20060101ALI20221028BHEP Ipc: C12R 1/01 20060101ALI20221028BHEP Ipc: C12N 1/20 20060101ALI20221028BHEP Ipc: A61P 1/00 20060101ALI20221028BHEP Ipc: A61K 35/745 20150101ALI20221028BHEP Ipc: A61K 35/747 20150101ALI20221028BHEP Ipc: A61K 35/741 20150101AFI20221028BHEP |